Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Bendamustine hydrochloride by Mecox Cure Med for Unspecified B-Cell Lymphomas: Likelihood of Approval
Bendamustine hydrochloride is under clinical development by Mecox Cure Med and currently in Phase I for Unspecified B-Cell Lymphomas. According...